合成路线1
该中间体在本合成路线中的序号:
(II) The condensation of 2,3-dichlorobenzaldehyde (I) with 2,2-dimethoxyethylamine (II) in refluxing toluene gives the corresponding Schiff base (III), which is reduced with H2 over PtO2 in ethyl acetate and acetylated with acetic anhydride yielding N-(2,3-dichlororobenzyl)-N-(2,2-dimethoxyethyl)acetamide (IV). The cyclization of (IV) with AlCl3 in dichloroethane affords 7,8-dichloro-2-acetyl-1,2-dihydroisoquinoline (V), which is submitted to cyclopropanation with CHCl3, NaOH and benzyltriethylammonium chloride giving 1,1,4,5-tetrachloro-2-acetyl-1a,2,3,7b-tetrahydro-1H-cycloprop[c]isoquinoline (VI). Ring opening of (VI) by refluxing with tert-butyl alcohol yields 2-acetyl-3-(tert-butoxy)-4,8,9-trichloro-2,3-dihydro-1H-2-benzazepine (VII), which is reduced with H2 over PtO2 in methanol affording 2-acetyl-8,9-dichloro 2,3,4,5-tetrahydro-1H-2-benzazepine (VIII). Finally, this compound is desacetylated by means of refluxing aqueous HCl.
【1】
Perchonock, C.D.; Lantos, I.; Holden, K.G.; Finkelstei, J.A.; Facile synthesis of halo-substituted tetrahydroisoquinolines and tetrahydro-2-benzazepines via N-acetyl-1,2-dihydroisoquinolines. J Org Chem 1980, 45, 10, 1950-53.
|
【2】
Serradell, M.N.; Castaner, J.; LY-134046. Drugs Fut 1984, 9, 4, 268.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
14742 |
2,3-dichlorobenzaldehyde
|
6334-18-5 |
C7H4Cl2O |
详情 | 详情
|
(II) |
34158 |
aminoacetaldehyde dimethylacetal; 2,2-dimethoxy-1-ethanamine; 2,2-dimethoxyethylamine
|
22483-09-6 |
C4H11NO2 |
详情 | 详情
|
(III) |
34159 |
N-[(Z)-(2,3-dichlorophenyl)methylidene]-2,2-dimethoxy-1-ethanamine; N-[(Z)-(2,3-dichlorophenyl)methylidene]-N-(2,2-dimethoxyethyl)amine
|
|
C11H13Cl2NO2 |
详情 |
详情
|
(IV) |
34160 |
N-(2,3-dichlorobenzyl)-N-(2,2-dimethoxyethyl)acetamide
|
|
C13H17Cl2NO3 |
详情 |
详情
|
(V) |
34161 |
1-[7,8-dichloro-2(1H)-isoquinolinyl]-1-ethanone
|
|
C11H9Cl2NO |
详情 |
详情
|
(VI) |
34162 |
1-(1,1,4,5-tetrachloro-1,1a,3,7b-tetrahydro-2H-cyclopropa[c]isoquinolin-2-yl)-1-ethanone
|
|
C12H9Cl4NO |
详情 |
详情
|
(VII) |
34163 |
1-[3-(tert-butoxy)-4,8,9-trichloro-1,3-dihydro-2H-2-benzazepin-2-yl]-1-ethanone
|
|
C16H18Cl3NO2 |
详情 |
详情
|
(VIII) |
34164 |
1-(8,9-dichloro-1,3,4,5-tetrahydro-2H-2-benzazepin-2-yl)-1-ethanone
|
|
C12H13Cl2NO |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(IV) The reaction of 4-phenyl-1-butanol (I) with 1,6-dibromohexane (II) by means of KOH and tetrabutylammonium bisulfate gives the butyl hexyl ether (III), which is condensed with 2-aminoacetaldehyde dimethylacetal (IV) in refluxing toluene yielding 2-[6-(4-phenylbutoxy)hexylamino]acetaldehyde dimethylacetal (V). The protection of the amino group of (V) with N-(benzyloxycarbonyloxy)succinimide and triethylamine in acetone affords the carbamate (VI), which is treated with TsOH in acetone to provide the acetaldehyde derivative (VII). The condensation of (VII) with 6-bromo-2,2-dimethyl-1,3-benzodioxan (VIII) (obtained by cyclization of phenol (IX) with acetone and AlCl3) by means of Mg in THF gives the expected carbinol (X), which is deprotected with H2 over Pd/C in methanol yielding the aminoethanol derivative (XI). Finally, this compound is treated with HCl in methanol/water to open the 1,3-dioxane ring and afford the target compound.
【1】
Marquillas Olondriz, F.; Dalmases Barjoan, P.; Bessa Bellmunt, J. (Laboratorios Vita, SA); New derivs. of 6-(4-phenylbutoxy)hexylamine and process for producing salmeterol. ES 2142771; WO 0018722 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
27291 |
4-phenyl-1-butanol
|
3360-41-6 |
C10H14O |
详情 | 详情
|
(II) |
24786 |
1,6-dibromohexane
|
629-03-8 |
C6H12Br2 |
详情 | 详情
|
(III) |
31479 |
1-[4-[(6-bromohexyl)oxy]butyl]benzene; 6-bromohexyl-4-phenylbutyl ether; 6-Bromohexyloxybutylbenzene
|
94749-73-2 |
C16H25BrO |
详情 | 详情
|
(IV) |
34158 |
aminoacetaldehyde dimethylacetal; 2,2-dimethoxy-1-ethanamine; 2,2-dimethoxyethylamine
|
22483-09-6 |
C4H11NO2 |
详情 | 详情
|
(V) |
36932 |
N-(2,2-dimethoxyethyl)-N-[6-(4-phenylbutoxy)hexyl]amine; N-(2,2-dimethoxyethyl)-6-(4-phenylbutoxy)-1-hexanamine
|
|
C20H35NO3 |
详情 |
详情
|
(VI) |
36933 |
benzyl 2,2-dimethoxyethyl[6-(4-phenylbutoxy)hexyl]carbamate
|
|
C28H41NO5 |
详情 |
详情
|
(VII) |
36934 |
benzyl 2-oxoethyl[6-(4-phenylbutoxy)hexyl]carbamate
|
|
C26H35NO4 |
详情 |
详情
|
(VIII) |
36935 |
4-bromo-2-(hydroxymethyl)phenol
|
2316-64-5 |
C7H7BrO2 |
详情 | 详情
|
(IX) |
36936 |
6-bromo-2,2-dimethyl-4H-1,3-benzodioxine
|
|
C10H11BrO2 |
详情 |
详情
|
(X) |
36937 |
benzyl 2-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-2-hydroxyethyl[6-(4-phenylbutoxy)hexyl]carbamate
|
|
C36H47NO6 |
详情 |
详情
|
(XI) |
36938 |
1-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-2-[[6-(4-phenylbutoxy)hexyl]amino]-1-ethanol
|
|
C28H41NO4 |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(XIII) The Grignard condensation of 1-tetralone (IX) with 4-chloro-3-methoxyphenylmagnesium bromide (X) in THF followed by a treatment with TsOH gives 4-(4-chloro-3-methoxyphenyl)-1,2-dihydronaphthalene (XI), which is oxidized with oxone and TsOH yielding the 2-tetralone (XII). The condensation of (XII) with 2-aminoacetaldehyde dimethylacetal (XIII) in toluene affords the enamine (XIV), which is reduced with BH3 / t-Bu-NH2 and AcOH in dichloromethane to give a 9:1 mixture of cis (XV) and trans (XVI) isomers that is epimerized with t-BuOK in DMSO/DMF to a 15:85 mixture from which the desired trans-diastereomer (XVI) is isolated. The cyclization of (XVI) with CH3SO3H in dichloromethane affords the tetracyclic compound (XVII), which is hydrogenated with BH3 / t-Bu-NH2 to provide the intermediate (XVIII). Finally, this compound is methylated with formaldehyde and formic acid to obtain the previously reported rac-(VIII) compound.
【1】
Berger, J.G.; Clader, J.W.; Chang, W.K.; Gold, E.H. (Schering Corp.); Fused benzazepines. EP 0230270; EP 0254737; JP 1988502348; WO 8704430 .
|
【2】
Draper, R.W.; et al.; Novel stereoselective syntheses of the fused benzazepine dopamine D1 antagonist (6aS,13bR)-11-chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-5-H-benzo[d]naphth[2,1-b]azepin-12-ol (Sch 39166): 1. Aziridinium salt based syntheses. Org Process Res Dev 1998, 2, 3, 175. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VIII) |
31779 |
(3aS,9bR)-12-chloro-11-methoxy-3-methyl-2,3,3a,4,5,9b-hexahydro-1H-naphtho[1,2-a][3]benzazepine; (3aS,9bR)-12-chloro-3-methyl-2,3,3a,4,5,9b-hexahydro-1H-naphtho[1,2-a][3]benzazepin-11-yl methyl ether
|
|
C20H22ClNO |
详情 |
详情
|
(IX) |
20720 |
3,4-dihydro-1(2H)-naphthalenone
|
529-34-0 |
C10H10O |
详情 | 详情
|
(X) |
36624 |
bromo(4-chloro-3-methoxyphenyl)magnesium
|
|
C7H6BrClMgO |
详情 |
详情
|
(XI) |
36625 |
4-(4-chloro-3-methoxyphenyl)-1,2-dihydronaphthalene; 2-chloro-5-(3,4-dihydro-1-naphthalenyl)phenyl methyl ether
|
|
C17H15ClO |
详情 |
详情
|
(XII) |
36626 |
1-(4-chloro-3-methoxyphenyl)-3,4-dihydro-2(1H)-naphthalenone
|
|
C17H15ClO2 |
详情 |
详情
|
(XIII) |
34158 |
aminoacetaldehyde dimethylacetal; 2,2-dimethoxy-1-ethanamine; 2,2-dimethoxyethylamine
|
22483-09-6 |
C4H11NO2 |
详情 | 详情
|
(XIV) |
36627 |
N-[1-(4-chloro-3-methoxyphenyl)-3,4-dihydro-2-naphthalenyl]-N-(2,2-dimethoxyethyl)amine; 1-(4-chloro-3-methoxyphenyl)-N-(2,2-dimethoxyethyl)-3,4-dihydro-2-naphthalenamine
|
|
C21H24ClNO3 |
详情 |
详情
|
(XV) |
36628 |
N-[(1R,2S)-1-(4-chloro-3-methoxyphenyl)-1,2,3,4-tetrahydro-2-naphthalenyl]-N-(2,2-dimethoxyethyl)amine; (1R,2S)-1-(4-chloro-3-methoxyphenyl)-N-(2,2-dimethoxyethyl)-1,2,3,4-tetrahydro-2-naphthalenamine
|
|
C21H26ClNO3 |
详情 |
详情
|
(XVI) |
36629 |
(1S,2S)-1-(4-chloro-3-methoxyphenyl)-N-(2,2-dimethoxyethyl)-1,2,3,4-tetrahydro-2-naphthalenamine; N-[(1S,2S)-1-(4-chloro-3-methoxyphenyl)-1,2,3,4-tetrahydro-2-naphthalenyl]-N-(2,2-dimethoxyethyl)amine
|
|
C21H26ClNO3 |
详情 |
详情
|
(XVII) |
36630 |
(3aS,9bR)-12-chloro-3a,4,5,9b-tetrahydro-3H-naphtho[1,2-a][3]benzazepin-11-yl methyl ether; (3aS,9bR)-12-chloro-11-methoxy-3a,4,5,9b-tetrahydro-3H-naphtho[1,2-a][3]benzazepine
|
|
C19H18ClNO |
详情 |
详情
|
(XVIII) |
36631 |
(3aS,9bR)-12-chloro-2,3,3a,4,5,9b-hexahydro-1H-naphtho[1,2-a][3]benzazepin-11-yl methyl ether; (3aS,9bR)-12-chloro-11-methoxy-2,3,3a,4,5,9b-hexahydro-1H-naphtho[1,2-a][3]benzazepine
|
|
C19H20ClNO |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(II) The condensation of 2,2-dimethyl-1,3-dioxan-5-one (I) with aminoacetaldehyde dimethyl acetal (II) followed by acetylation with Ac2O/Et3N afforded the amido dioxin (III). Retro Diels-Alder reaction of dioxin (III) in warm benzonitrile generated the amidoacrolein (V), which was trapped in situ with the silyloxydiene (IV) to yield the cycloadduct (VI). Aldol cyclization between the acetamide and aldehyde functionalities of (VI) in the presence of t-BuOK produced the spiro lactam (VII). Subsequent aldol condensation between the acetal and silyl enolate functions of (VII) under acidic conditions furnished the tricyclic hydroxy ketone (VIII). Reduction of the keto group of (VIII) with NaBH(OAc)3 produced the C-4 axial alcohol (IX). Silylation of both hydroxyl groups of (IX) followed by selective cleavage of the C-2 silyl ether provided the C-4 mono silylated derivative (X). The free C-2 hydroxyl group of (X) was then oxidized to the corresponding ketone (XI) under Swern conditions. The potassium enolate of (XI) was stereoselectively alkylated with p-methoxybenzyl bromide (XII) to yield (XIII). Reduction of the keto group of (XIII) with Red-Al gave rise to the alcohol (XIV) in the undesired equatorial configuration. Inversion of the C-2 stereogenic center of (XIV) was achieved via formation of the sulfonate ester (XVI) with 4-nitrobenzenesulfonyl chloride (XV).
【1】
Maeng, J.-H.; Funk, R.L.; Total synthesis of the immunosuppressant FR901483 via an amidoacrolein cycloaddition. Org Lett 2001, 3, 8, 1125.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
46538 |
2,2-dimethyl-1,3-dioxan-5-one
|
|
C6H10O3 |
详情 |
详情
|
(II) |
34158 |
aminoacetaldehyde dimethylacetal; 2,2-dimethoxy-1-ethanamine; 2,2-dimethoxyethylamine
|
22483-09-6 |
C4H11NO2 |
详情 | 详情
|
(III) |
48300 |
N-(2,2-dimethoxyethyl)-N-(2,2-dimethyl-4H-1,3-dioxin-5-yl)acetamide
|
|
C12H21NO5 |
详情 |
详情
|
(IV) |
48301 |
triisopropyl[(1-methylene-2-propenyl)oxy]silane; 1-methylene-2-propenyl triisopropylsilyl ether
|
|
C13H26OSi |
详情 |
详情
|
(V) |
48302 |
N-(2,2-dimethoxyethyl)-N-(1-formylvinyl)acetamide
|
|
C9H15NO4 |
详情 |
详情
|
(VI) |
48303 |
N-(2,2-dimethoxyethyl)-N-[1-formyl-4-[(triisopropylsilyl)oxy]-3-cyclohexen-1-yl]acetamide
|
|
C22H41NO5Si |
详情 |
详情
|
(VII) |
48304 |
1-(2,2-dimethoxyethyl)-8-[(triisopropylsilyl)oxy]-1-azaspiro[4.5]deca-3,7-dien-2-one
|
|
C22H39NO4Si |
详情 |
详情
|
(VIII) |
48305 |
(1S,7R,8R)-7-hydroxy-5-azatricyclo[6.3.1.0(1,5)]dodec-2-ene-4,9-dione
|
|
C11H13NO3 |
详情 |
详情
|
(IX) |
48306 |
(1S,7R,8S,9S)-7,9-dihydroxy-5-azatricyclo[6.3.1.0(1,5)]dodec-2-en-4-one
|
|
C11H15NO3 |
详情 |
详情
|
(X) |
48307 |
(1S,7R,8R,9S)-9-[[tert-butyl(dimethyl)silyl]oxy]-7-hydroxy-5-azatricyclo[6.3.1.0(1,5)]dodec-2-en-4-one
|
|
C17H29NO3Si |
详情 |
详情
|
(XI) |
48308 |
(1S,8S,9S)-9-[[tert-butyl(dimethyl)silyl]oxy]-5-azatricyclo[6.3.1.0(1,5)]dodec-2-ene-4,7-dione
|
|
C17H27NO3Si |
详情 |
详情
|
(XII) |
27490 |
1-(bromomethyl)-4-methoxybenzene
|
|
C8H9BrO |
详情 |
详情
|
(XIII) |
48309 |
(1S,6S,8S,9S)-9-[[tert-butyl(dimethyl)silyl]oxy]-6-(4-methoxybenzyl)-5-azatricyclo[6.3.1.0(1,5)]dodec-2-ene-4,7-dione
|
|
C25H35NO4Si |
详情 |
详情
|
(XIV) |
48310 |
(1S,6S,7R,8R,9S)-9-[[tert-butyl(dimethyl)silyl]oxy]-7-hydroxy-6-(4-methoxybenzyl)-5-azatricyclo[6.3.1.0(1,5)]dodec-2-en-4-one
|
|
C25H37NO4Si |
详情 |
详情
|
(XV) |
15809 |
4-nitrobenzenesulfonyl chloride
|
98-74-8 |
C6H4ClNO4S |
详情 | 详情
|
(XVI) |
48311 |
(1S,6S,7R,8S,9S)-9-[[tert-butyl(dimethyl)silyl]oxy]-6-(4-methoxybenzyl)-4-oxo-5-azatricyclo[6.3.1.0(1,5)]dodec-2-en-7-yl 4-nitrobenzenesulfonate
|
|
C31H40N2O8SSi |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(II) The condensation of acetonide (I) with 2-aminoacetaldehyde dimethylacetal (II) by means of Ac2O and TEA gives the acetylated enamine (III), which is cyclocondensed with the silylated butadiene (IV) in hot benzonitrile to yield the cycloadduct (V). The cyclization of (V) by means of tBu-OK in ethyl acetate/THF, followed by desilylation with TFA, affords the tricyclic lactam (VI), which is reduced with NaBH(OAc)3 to provide the dihydroxy compound (VII). The silylation of both OH groups of (VII) by means of Tbdms-Cl, followed by selective desilylation of the equatorial silyl ether with TBAF, gives the corresponding alcohol (VIII), which is submitted to a Swern oxidation to yield the ketone (IX). The condensation of (IX) with 4-methoxybenzyl bromide (X) by means of tBu-OK and Red-Al affords the hydroxylated adduct (XI); however, the resulting alcohol presents an unnatural equatorial configuration that is inverted by its esterification with 4-nitrophenylsulfonyl chloride to furnish (XII), followed by acetoxylation of (XII) with rubidium acetate and 18-crown-6, to provide the desired axial acetoxy compound (XIII). The hydrolysis of (XIII) with KOH in methanol gives the corresponding alcohol (XIV), which is silylated with Tes-Otf to yield the bis silyl ether (XV). The reduction of the double bond of (XV) with H2 over PtO2 affords the saturated compound (XVI), which is treated with triethylsilylazide and LDA to provide at the azido compound (XVII). The reduction of lactam and azido groups by means of LiAlH4, followed by protection of the resulting amino group with benzyloxycarbonyl chloride and Na2CO3, gives the benzyl carbamate (XVIII).
【1】
Maeng, J.-H.; Funk, R.L.; Total synthesis of the immunosuppressant FR901483 via an amidoacrolein cycloaddition. Org Lett 2001, 3, 8, 1125.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
46538 |
2,2-dimethyl-1,3-dioxan-5-one
|
|
C6H10O3 |
详情 |
详情
|
(II) |
34158 |
aminoacetaldehyde dimethylacetal; 2,2-dimethoxy-1-ethanamine; 2,2-dimethoxyethylamine
|
22483-09-6 |
C4H11NO2 |
详情 | 详情
|
(III) |
48300 |
N-(2,2-dimethoxyethyl)-N-(2,2-dimethyl-4H-1,3-dioxin-5-yl)acetamide
|
|
C12H21NO5 |
详情 |
详情
|
(IV) |
48301 |
triisopropyl[(1-methylene-2-propenyl)oxy]silane; 1-methylene-2-propenyl triisopropylsilyl ether
|
|
C13H26OSi |
详情 |
详情
|
(V) |
48303 |
N-(2,2-dimethoxyethyl)-N-[1-formyl-4-[(triisopropylsilyl)oxy]-3-cyclohexen-1-yl]acetamide
|
|
C22H41NO5Si |
详情 |
详情
|
(VI) |
48305 |
(1S,7R,8R)-7-hydroxy-5-azatricyclo[6.3.1.0(1,5)]dodec-2-ene-4,9-dione
|
|
C11H13NO3 |
详情 |
详情
|
(VII) |
48306 |
(1S,7R,8S,9S)-7,9-dihydroxy-5-azatricyclo[6.3.1.0(1,5)]dodec-2-en-4-one
|
|
C11H15NO3 |
详情 |
详情
|
(VIII) |
48307 |
(1S,7R,8R,9S)-9-[[tert-butyl(dimethyl)silyl]oxy]-7-hydroxy-5-azatricyclo[6.3.1.0(1,5)]dodec-2-en-4-one
|
|
C17H29NO3Si |
详情 |
详情
|
(IX) |
48308 |
(1S,8S,9S)-9-[[tert-butyl(dimethyl)silyl]oxy]-5-azatricyclo[6.3.1.0(1,5)]dodec-2-ene-4,7-dione
|
|
C17H27NO3Si |
详情 |
详情
|
(X) |
27490 |
1-(bromomethyl)-4-methoxybenzene
|
|
C8H9BrO |
详情 |
详情
|
(XI) |
48310 |
(1S,6S,7R,8R,9S)-9-[[tert-butyl(dimethyl)silyl]oxy]-7-hydroxy-6-(4-methoxybenzyl)-5-azatricyclo[6.3.1.0(1,5)]dodec-2-en-4-one
|
|
C25H37NO4Si |
详情 |
详情
|
(XII) |
48311 |
(1S,6S,7R,8S,9S)-9-[[tert-butyl(dimethyl)silyl]oxy]-6-(4-methoxybenzyl)-4-oxo-5-azatricyclo[6.3.1.0(1,5)]dodec-2-en-7-yl 4-nitrobenzenesulfonate
|
|
C31H40N2O8SSi |
详情 |
详情
|
(XIII) |
48313 |
(1S,6S,7S,8R,9S)-9-[[tert-butyl(dimethyl)silyl]oxy]-6-(4-methoxybenzyl)-4-oxo-5-azatricyclo[6.3.1.0(1,5)]dodec-2-en-7-yl acetate
|
|
C27H39NO5Si |
详情 |
详情
|
(XIV) |
48314 |
(1S,6S,7S,8R,9S)-9-[[tert-butyl(dimethyl)silyl]oxy]-7-hydroxy-6-(4-methoxybenzyl)-5-azatricyclo[6.3.1.0(1,5)]dodec-2-en-4-one
|
|
C25H37NO4Si |
详情 |
详情
|
(XV) |
48315 |
(1S,6S,7S,8R,9S)-9-[[tert-butyl(dimethyl)silyl]oxy]-6-(4-methoxybenzyl)-7-[(triethylsilyl)oxy]-5-azatricyclo[6.3.1.0(1,5)]dodec-2-en-4-one
|
|
C31H51NO4Si2 |
详情 |
详情
|
(XVI) |
48316 |
(1R,6S,7S,8R,9S)-9-[[tert-butyl(dimethyl)silyl]oxy]-6-(4-methoxybenzyl)-7-[(triethylsilyl)oxy]-5-azatricyclo[6.3.1.0(1,5)]dodecan-4-one
|
|
C31H53NO4Si2 |
详情 |
详情
|
(XVII) |
48317 |
(1S,3S,6S,7S,8R,9S)-3-azido-9-[[tert-butyl(dimethyl)silyl]oxy]-6-(4-methoxybenzyl)-7-[(triethylsilyl)oxy]-5-azatricyclo[6.3.1.0(1,5)]dodecan-4-one
|
|
C31H52N4O4Si2 |
详情 |
详情
|
(XVIII) |
48319 |
benzyl (1S,3S,6S,7S,8R,9S)-9-[[tert-butyl(dimethyl)silyl]oxy]-7-hydroxy-6-(4-methoxybenzyl)-5-azatricyclo[6.3.1.0(1,5)]dodec-3-ylcarbamate
|
|
C33H48N2O5Si |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(II) The cyclization of 2-methylphenyl isothiocyanate (I) with 2-aminoacetaldehyde dimethylacetal (II) in methanol gives the 1-(2-methylphenyl)imidazole-2-thiol (III), which is condensed with 3-bromopropanol (IV) by means of NaOH in refluxing water to yield the sulfide (V). The asymmetric oxidation of sulfide (V) with Ti(O-iPr)4, cumene hydroperoxide (CHP) and (R)-(-)-mandelic acid as chiral catalyst in dichloromethane affords the (S)-sulfinyl derivative (VI), which is treated with Ms-Cl to provide the expected mesylate (VII). Finally, this compound is condensed with the sodium salt of 6-hydroxy-1,2,3,4-tetrahydroquinolin-2one (VIII) to give the target compound.
【1】
Matsugi, M.; et al.; Catalytic asymmetric oxidation of sulfide with titanium-mandelic acid complex: Practical synthesis of (S)-3-[1-(2-methylphenyl)imidazol-2-ylsulfinyl]propan-1-ol, the key intermediate of OPC-29030. Tetrahedron 2001, 57, 14, 2739.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
50207 |
6-isothiocyanato-1-methyl-1,3-cyclohexadiene; 2-methyl-2,4-cyclohexadien-1-yl isothiocyanate
|
|
C8H9NS |
详情 |
详情
|
(II) |
34158 |
aminoacetaldehyde dimethylacetal; 2,2-dimethoxy-1-ethanamine; 2,2-dimethoxyethylamine
|
22483-09-6 |
C4H11NO2 |
详情 | 详情
|
(III) |
30223 |
1-(2-methylphenyl)-1H-imidazol-2-ylhydrosulfide; 1-(2-methylphenyl)-1H-imidazole-2-thiol
|
|
C10H10N2S |
详情 |
详情
|
(IV) |
12573 |
3-Bromo-1-propanol; 3-Bromopropanol
|
627-18-9 |
C3H7BrO |
详情 | 详情
|
(V) |
30239 |
3-[[1-(2-methylphenyl)-1H-imidazol-2-yl]sulfanyl]-1-propanol
|
|
C13H16N2OS |
详情 |
详情
|
(VI) |
50208 |
(3-hydroxypropyl)[1-(2-methylphenyl)-1H-imidazol-2-yl]sulfoniumolate
|
|
C13H16N2O2S |
详情 |
详情
|
(VII) |
50209 |
[1-(2-methylphenyl)-1H-imidazol-2-yl][3-[(methylsulfonyl)oxy]propyl]sulfoniumolate
|
|
C14H18N2O4S2 |
详情 |
详情
|
(VIII) |
50210 |
|
|
C9H8NNaO2 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(X) Alkylation of isovanillin (I) with 2-indanyl tosylate (II) produces the corresponding indanyl ether (III). Subsequent reduction of the aldehyde function of (III) with NaBH4 yields the benzylic alcohol (IV), which is converted to chloride (V) by treatment with SOCl2. Displacement of chloride (V) by KCN in hot DMF gives nitrile (VI). The phenylacetonitrile (VI) is then converted to the homologous phenylpropionitrile derivative (VII) by alkylation with iodomethane in the presence of LDA. Further cyano group reduction in (VII) by hydrogenation over Raney Ni provides amine (VIII). Condensation of amine (VIII) with diphenyl N-cyanocarbonimidate affords the N-cyano isourea (IX) which, after reaction with 2,2-dimethoxyethylamine (X), yields the cyano guanidine (XI). Finally, cyclization of (XI) under acidic conditions gives rise to the target 2-(cyanoimino)imidazole derivative.
【1】
Diaz, A.; Andres, J.I.; Alonso, J.M.; et al.; Synthesis and biological evaluation of imidazol-2-one and 2-cyanoiminoimidazole derivatives: Novel series of PDE4 inhibitors. Bioorg Med Chem Lett 2002, 12, 4, 653.
|
【2】
Freyne, E.J.E.; Fernandez-Gadea, F.J.; Andres-Gil, J.I. (Janssen Pharmaceutica NV); PDE IV inhibiting 2-cyanoiminoimidazole derivs.. WO 9814432 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18455 |
3-hydroxy-4-methoxybenzaldehyde; Isovanillin
|
621-59-0 |
C8H8O3 |
详情 | 详情
|
(II) |
57734 |
2-Indanyl p-toluenesulphonate
|
17783-69-6 |
C16H16O3S |
详情 | 详情
|
(III) |
57735 |
3-(2,3-dihydro-1H-inden-2-yloxy)-4-methoxybenzaldehyde
|
|
C17H16O3 |
详情 |
详情
|
(IV) |
57736 |
[3-(2,3-dihydro-1H-inden-2-yloxy)-4-methoxyphenyl]methanol
|
|
C17H18O3 |
详情 |
详情
|
(V) |
57737 |
2-[5-(chloromethyl)-2-methoxyphenoxy]indane; 4-(chloromethyl)-2-(2,3-dihydro-1H-inden-2-yloxy)phenyl methyl ether
|
|
C17H17ClO2 |
详情 |
详情
|
(VI) |
57738 |
2-[3-(2,3-dihydro-1H-inden-2-yloxy)-4-methoxyphenyl]acetonitrile
|
|
C18H17NO2 |
详情 |
详情
|
(VII) |
57739 |
2-[3-(2,3-dihydro-1H-inden-2-yloxy)-4-methoxyphenyl]propanenitrile
|
|
C19H19NO2 |
详情 |
详情
|
(VIII) |
57740 |
2-[3-(2,3-dihydro-1H-inden-2-yloxy)-4-methoxyphenyl]-1-propanamine; 2-[3-(2,3-dihydro-1H-inden-2-yloxy)-4-methoxyphenyl]propylamine
|
|
C19H23NO2 |
详情 |
详情
|
(IX) |
57741 |
2-[5-(2-{[(cyanoimino)(phenoxy)methyl]amino}-1-methylethyl)-2-methoxyphenoxy]indane
|
|
C27H27N3O3 |
详情 |
详情
|
(X) |
34158 |
aminoacetaldehyde dimethylacetal; 2,2-dimethoxy-1-ethanamine; 2,2-dimethoxyethylamine
|
22483-09-6 |
C4H11NO2 |
详情 | 详情
|
(XI) |
57742 |
N''-cyano-N-{2-[3-(2,3-dihydro-1H-inden-2-yloxy)-4-methoxyphenyl]propyl}-N'-(2,2-dimethoxyethyl)guanidine
|
|
C25H32N4O4 |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(IV) The bromo pyrazinone intermediate (VII) has been obtained as follows. The condensation of ethyl glycinate (I) with ethoxalyl chloride (II) by means of TEA in dichloroethane gives the corresponding amide (III), which is condensed with aminoacetaldehyde dimethyl acetal (IV) in isopropanol to yield the diamide (V). The cyclization of (V) by means of HCl in refluxing AcOH affords the hydroxypyrazinone (VI), which is finally treated with POBr3 in refluxing 1,2-dichloroethane to provide the target bromopyrazinone intermediate (VII) (1).
【1】
Selnick, H.G.; Newton, R.C.; Newton, C.L.; Barrow, J.C.; Nantermet, P.G. (Merck & Co., Inc.); Thrombin inhibitors. WO 0311222 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11043 |
Ethyl 2-chloro-2-oxoacetate; Ethyl oxalyl chloride
|
4755-77-5 |
C4H5ClO3 |
详情 | 详情
|
(II) |
17568 |
methyl 2-aminoacetate
|
|
C3H7NO2 |
详情 |
详情
|
(III) |
63817 |
ethyl 2-oxo-2-[(2-oxo-2-propoxyethyl)amino]acetate
|
|
C9H15NO5 |
详情 |
详情
|
(IV) |
34158 |
aminoacetaldehyde dimethylacetal; 2,2-dimethoxy-1-ethanamine; 2,2-dimethoxyethylamine
|
22483-09-6 |
C4H11NO2 |
详情 | 详情
|
(V) |
63818 |
propyl 2-({2-[(2,2-dimethoxyethyl)amino]-2-oxoacetyl}amino)acetate
|
|
C11H20N2O6 |
详情 |
详情
|
(VI) |
63819 |
propyl 2-[3-hydroxy-2-oxo-1(2H)-pyrazinyl]acetate
|
|
C9H12N2O4 |
详情 |
详情
|
(VII) |
63820 |
propyl 2-[3-bromo-2-oxo-1(2H)-pyrazinyl]acetate
|
|
C9H11BrN2O3 |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(XIII) Acylation of glycine ethyl ester (X) with ethyl oxalyl chloride (XI) provides the oxalic acid mono-amide (XII). Subsequent condensation of (XII) with aminoacetaldehyde dimethylacetal (XIII) affords the diamide (XIV). Cyclization of (XIV) under acetal hydrolysis conditions leads to pyrazinone (XV). This is then brominated to (XVI) employing POBr3 in refluxing dichloroethane. Condensation of the bromopyrazinone (XVI) with amine (IX) at 120 C in a sealed vessel furnishes the aminopyrazinone (XVII). After chlorination of (XVII) with N-chlorosuccinimide, the resultant chloropyrazine ester (XVIII) is hydrolyzed to acid (XIX) under alkaline conditions
【1】
Selnick, H.G.; Rittle, K.E.; Barrow, J.C.; Morrissette, M.M.; Nantermet, P.G.; Staas, D. (Merck & Co., Inc.); Thrombin inhibitors. WO 0257225 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IX) |
63218 |
2-(2-amino-1,1-difluoroethyl)-1-pyridiniumolate
|
|
C7H8F2N2O |
详情 |
详情
|
(X) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(XI) |
11043 |
Ethyl 2-chloro-2-oxoacetate; Ethyl oxalyl chloride
|
4755-77-5 |
C4H5ClO3 |
详情 | 详情
|
(XII) |
63556 |
ethyl 2-[(2-ethoxy-2-oxoethyl)amino]-2-oxoacetate
|
|
C8H13NO5 |
详情 |
详情
|
(XIII) |
34158 |
aminoacetaldehyde dimethylacetal; 2,2-dimethoxy-1-ethanamine; 2,2-dimethoxyethylamine
|
22483-09-6 |
C4H11NO2 |
详情 | 详情
|
(XIV) |
63557 |
ethyl 2-({2-[(2,2-dimethoxyethyl)amino]-2-oxoacetyl}amino)acetate
|
|
C10H18N2O6 |
详情 |
详情
|
(XV) |
63558 |
ethyl 2-[2,3-dioxo-3,4-dihydro-1(2H)-pyrazinyl]acetate
|
|
C8H10N2O4 |
详情 |
详情
|
(XVI) |
63219 |
ethyl 2-[3-bromo-2-oxo-1(2H)-pyrazinyl]acetate
|
|
C8H9BrN2O3 |
详情 |
详情
|
(XVII) |
63220 |
2-(2-{[4-(2-ethoxy-2-oxoethyl)-3-oxo-3,4-dihydro-2-pyrazinyl]amino}-1,1-difluoroethyl)-1-pyridiniumolate
|
|
C15H16F2N4O4 |
详情 |
详情
|
(XVIII) |
63221 |
2-(2-{[5-chloro-4-(2-ethoxy-2-oxoethyl)-3-oxo-3,4-dihydro-2-pyrazinyl]amino}-1,1-difluoroethyl)-1-pyridiniumolate
|
|
C15H15ClF2N4O4 |
详情 |
详情
|
(XIX) |
63222 |
2-(2-{[4-(carboxymethyl)-5-chloro-3-oxo-3,4-dihydro-2-pyrazinyl]amino}-1,1-difluoroethyl)-1-pyridiniumolate
|
|
C13H11ClF2N4O4 |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(IV) Acylation of glycine ethyl ester (I) with ethyl oxalyl chloride (II) affords amide (III). Subsequent reaction of (III) with aminoacetaldehyde dimethyl acetal (IV) produces the oxalic acid diamide (V). Cyclization of (V) under acidic conditions furnishes the pyrazine dione (VI), which is further brominated to (VII) employing phosphorus oxybromide.
【1】
Selnick, H.G.; Newton, R.C.; Newton, C.L.; Barrow, J.C.; Nantermet, P.G. (Merck & Co., Inc.); Thrombin inhibitors. WO 0311222 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(II) |
11043 |
Ethyl 2-chloro-2-oxoacetate; Ethyl oxalyl chloride
|
4755-77-5 |
C4H5ClO3 |
详情 | 详情
|
(III) |
63556 |
ethyl 2-[(2-ethoxy-2-oxoethyl)amino]-2-oxoacetate
|
|
C8H13NO5 |
详情 |
详情
|
(IV) |
34158 |
aminoacetaldehyde dimethylacetal; 2,2-dimethoxy-1-ethanamine; 2,2-dimethoxyethylamine
|
22483-09-6 |
C4H11NO2 |
详情 | 详情
|
(V) |
63557 |
ethyl 2-({2-[(2,2-dimethoxyethyl)amino]-2-oxoacetyl}amino)acetate
|
|
C10H18N2O6 |
详情 |
详情
|
(VI) |
63558 |
ethyl 2-[2,3-dioxo-3,4-dihydro-1(2H)-pyrazinyl]acetate
|
|
C8H10N2O4 |
详情 |
详情
|
(VII) |
63219 |
ethyl 2-[3-bromo-2-oxo-1(2H)-pyrazinyl]acetate
|
|
C8H9BrN2O3 |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(XXVI) Condensation of ethyl 3-(dimethylamino)acrylate (XVIII) with (benzyloxy)acetyl chloride (XIX) by means of pyridine in CH2Cl2 gives ethyl 2-[(benzyloxy)acetyl]-3-(dimethylamino)-2-propenoate (XX), which by cyclocondensation with ethyl oxalyl chloride (XXI) in the presence of LiHMDS in THF at –78 °C followed by heating with NH4OAc and AcOH affords pyridone derivative (XXII). Alkylation of pyridone (XXII) with bromoacetaldehyde dimethyl acetal (XXIII) and Cs2CO3 in DMF yields diethyl 1-(2,2-dimethoxyethyl)-3-(benzyloxy)-1,4-dihydropyridine-2,5-dicarboxylate (XXIV), which can also be obtained by condensation of diethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate (XXV) with 2,2-dimethoxyethylamine (XXVI) in EtOH. Hydrolysis of acetal (XXIV) with H2SO4 and HCOOH in CH2Cl2 yields aldehyde (XXVII), which upon cyclocondensation with 3(R)-amino-1-butanol (XI) by means of AcOH in refluxing MeOH/toluene provides the hexahydropyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine derivative (XXVIII). Hydrolysis of ester (XXVIII) with NaOH in THF/MeOH/H2O gives the corresponding free acid (XXIX), which is finally condensed with 2,4-difluorobenzylamine (XIV) in the presence of HATU and NMM in DMF .
Propenoate (XX) can also be prepared by condensation of ethyl 4-chloroacetoacetate (XXX) with PhCH2OH in the presence of t-AmONa to give benzyl ether (XXXI), which then reacts with N,N-dimethylformamide dimethyl acetal (XXXII) in toluene .
【1】
Sumino, Y., Okamoto, K., Masui, M., Yamada, D., Ikarashi, F. (Shionogi & Co., Ltd.). Process for preparing compound having HIV integrase inhibitory activity. WO 2012018065. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XI) |
68577 |
3(R)-amino-1-butanol;(R)-3-aminobutan-1-ol |
61477-39-2 |
C4H11NO |
详情 | 详情
|
(XIV) |
68578 |
2,4-difluorobenzylamine |
72235-52-0 |
C7H7F2N |
详情 | 详情
|
(XV) |
68579 |
(4R,12aS)-7-(benzyloxy)-N-(2,4-difluorobenzyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide |
|
C27H25F2N3O5 |
详情 | 详情
|
(XVIII) |
16000 |
ethyl (E)-3-(dimethylamino)-2-propenoate; Ethyl trans-3-dimethylaminoacrylate
|
1117-37-9 |
C7H13NO2 |
详情 | 详情
|
(XIX) |
10493 |
2-(Benzyloxy)acetyl chloride; Benzyloxyacetyl chloride
|
19810-31-2 |
C9H9ClO2 |
详情 | 详情
|
(XX) |
68583 |
(E)-ethyl 4-(benzyloxy)-2-((dimethylamino)methylene)-3-oxobutanoate |
|
C16H21NO4 |
详情 | 详情
|
(XXI) |
11043 |
Ethyl 2-chloro-2-oxoacetate; Ethyl oxalyl chloride
|
4755-77-5 |
C4H5ClO3 |
详情 | 详情
|
(XXII) |
68584 |
diethyl 3-(benzyloxy)-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate |
|
C18H19NO6 |
详情 | 详情
|
(XXIII) |
13183 |
2-Bromo-1,1-dimethoxyethane; 2-Bromo-1-methoxyethyl methyl ether; Bromoacetaldehyde dimethyl acetal
|
7252-83-7 |
C4H9BrO2 |
详情 | 详情
|
(XXIV) |
68585 |
1-(2,2-dimethoxyethyl)-3-(benzyloxy)-1,4-dihydropyridine-2,5-dicarboxylate diethyl;diethyl 3-(benzyloxy)-1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate |
|
C22H27NO8 |
详情 | 详情
|
(XXV) |
68586 |
diethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate |
|
C18H18O7 |
详情 | 详情
|
(XXVI) |
34158 |
aminoacetaldehyde dimethylacetal; 2,2-dimethoxy-1-ethanamine; 2,2-dimethoxyethylamine
|
22483-09-6 |
C4H11NO2 |
详情 | 详情
|
(XXVII) |
68587 |
diethyl 3-(benzyloxy)-4-oxo-1-(2-oxoethyl)-1,4-dihydropyridine-2,5-dicarboxylate |
|
C20H21NO7 |
详情 | 详情
|
(XXVIII) |
68588 |
(4R,12aS)-ethyl 7-(benzyloxy)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylate |
|
C22H24N2O6 |
详情 | 详情
|
(XXIX) |
68589 |
(4R,12aS)-7-(benzyloxy)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid |
|
C20H20N2O6 |
详情 | 详情
|
(XXX) |
23541 |
ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloroacetoacetate |
638-07-3 |
C6H9ClO3 |
详情 | 详情
|
(XXXI) |
68590 |
ethyl 4-(benzyloxy)-3-oxobutanoate |
|
C13H16O4 |
详情 | 详情
|
(XXXII) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
合成路线12
该中间体在本合成路线中的序号:
(XXVI) Condensation of methyl 4-chloroacetoacetate (XXXIII) with PhCH2OH in the presence of t-AmONa in THF gives the benzyl ether (XXXIV), which is then condensed with N,N-dimethylformamide dimethyl acetal (XXXII) in dioxane to give methyl 2-[(benzyloxy) acetyl]-3-aminoacrylate (XXXV). Cyclocondensation of acrylate (XXXV) with dimethyl oxalate by means of t-BuONa provides the pyranone derivative (XXXVII), which is then reacted with aminoacetaldehyde dimethyl acetal (XXVI) at reflux to yield pyridone (XXXVIII). Hydrolysis of acetal (XXXVIII) with H2SO4 and HCOOH affords aldehyde (XXXIX), which upon cyclocondensation with 3(R)-amino-1-butanol (XI) in the presence of AcOH in refluxing MeOH/toluene gives the hexahydropyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine derivative (XL). Finally, methyl ester (XL) is condensed with 2,4-difluorobenzylamine (XIV) in the presence of AcOH in toluene .
Alternatively, coupling of methyl ester (XXXVIII) with 2,4-difluorobenzylamine (XIV) by means of AcOH in toluene/MeOH gives amide (XLI), which upon acetal hydrolysis with H2SO4 and HCOOH in toluene yields aldehyde (XLII). Finally, aldehyde (XLII) is submitted to cyclocondensation with 3(R)-amino-1-butanol (XI) in the presence of AcOH in refluxing MeOH/toluene .
【1】
Sumino, Y., Okamoto, K., Masui, M., Yamada, D., Ikarashi, F. (Shionogi & Co., Ltd.). Process for preparing compound having HIV integrase inhibitory activity. WO 2012018065. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XL) |
68597 |
(4R,12aS)-methyl 7-(benzyloxy)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylate |
|
C21H22N2O6 |
详情 | 详情
|
(XI) |
68577 |
3(R)-amino-1-butanol;(R)-3-aminobutan-1-ol |
61477-39-2 |
C4H11NO |
详情 | 详情
|
(XIV) |
68578 |
2,4-difluorobenzylamine |
72235-52-0 |
C7H7F2N |
详情 | 详情
|
(XV) |
68579 |
(4R,12aS)-7-(benzyloxy)-N-(2,4-difluorobenzyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide |
|
C27H25F2N3O5 |
详情 | 详情
|
(XXVI) |
34158 |
aminoacetaldehyde dimethylacetal; 2,2-dimethoxy-1-ethanamine; 2,2-dimethoxyethylamine
|
22483-09-6 |
C4H11NO2 |
详情 | 详情
|
(XXXII) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(XXXIII) |
68591 |
methyl 4-chloro-3-oxobutanoate;Methyl 4-chloro-3-oxo-butanoate;Methyl 4-chloro-3-oxobutyrate;Methyl 4-chloroacetoacetate |
32807-28-6 |
C5H7ClO3 |
详情 | 详情
|
(XXXIV) |
68592 |
methyl 4-(benzyloxy)-3-oxobutanoate |
|
C12H14O4 |
详情 | 详情
|
(XXXV) |
68593 |
(E)-methyl 4-(benzyloxy)-2-((dimethylamino)methylene)-3-oxobutanoate;methyl 2-[(benzyloxy)acetyl]-3-aminoacrylate |
|
C15H19NO4 |
详情 | 详情
|
(XXXVI) |
37412 |
methyl 2-methoxy-2-oxoacetate;dimethyl oxalate;Methyl oxalate |
553-90-2 |
C4H6O4 |
详情 | 详情
|
(XXXVII) |
68594 |
dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate |
|
C16H14O7 |
详情 | 详情
|
(XXXVIII) |
68595 |
dimethyl 3-(benzyloxy)-1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate |
|
C20H23NO8 |
详情 | 详情
|
(XXXIX) |
68596 |
dimethyl 3-(benzyloxy)-4-oxo-1-(2-oxoethyl)-1,4-dihydropyridine-2,5-dicarboxylate |
|
C18H17NO7 |
详情 | 详情
|
(XLI) |
68598 |
methyl 3-(benzyloxy)-5-((2,4-difluorobenzyl)carbamoyl)-1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2-carboxylate |
|
C26H26F2N2O7 |
详情 | 详情
|
(XLII) |
68599 |
methyl 3-(benzyloxy)-5-((2,4-difluorobenzyl)carbamoyl)-4-oxo-1-(2-oxoethyl)-1,4-dihydropyridine-2-carboxylate |
|
C24H20F2N2O6 |
详情 | 详情
|
合成路线13
该中间体在本合成路线中的序号:
(XXVI) Condensation of methyl 4-methoxyacetoacetate (XLIII) with N,N-dimethylformamide dimethyl acetal (XXXII) produces methyl 3-(dimethylamino)-2-(methoxyacetyl)-2-propenoate (XLIV), which by reaction with 2,2-dimethoxyethylamine (XXVI) in MeOH affords the N-(dimethyoxyethyl)enamine (XLV). Cyclization of enaminoketone (XLV) with dimethyl oxalate (XXXVI) by means of LiH at 40 °C gives the dimethyl pyridone-dicarboxylate (XLVI), which by selective hydrolysis with LiOH yields the monocarboxylic acid (XLVII). Hydrolysis of acetal (XLVII) with MsOH and AcOH in acetonitrile at 58-65 °C followed by in situ cyclization of the resulting aldehyde (XLVIII) with 3(R)-amino-1-butanol (XI) in acetonitrile at 64 °C affords the pyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine derivative (XLIX). Activation of acid (XLIX) with CDI in DME at 80 °C and subsequent coupling with 2,4-difluorobenzylamine (XIV) gives amide (L), which is finally O-demethylated with either MgBr2 in hot acetonitrile or LiBr in refluxing THF .
【1】
Wang, H., Goodman, S.N., Mans, D., Kowalski, M. (GlaxoSmithKline, Inc.). Process for preparing carbamoylpyridone derivatives and intermediates. WO 2011119566. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XI) |
68577 |
3(R)-amino-1-butanol;(R)-3-aminobutan-1-ol |
61477-39-2 |
C4H11NO |
详情 | 详情
|
(XIV) |
68578 |
2,4-difluorobenzylamine |
72235-52-0 |
C7H7F2N |
详情 | 详情
|
(XV) |
68579 |
(4R,12aS)-7-(benzyloxy)-N-(2,4-difluorobenzyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide |
|
C27H25F2N3O5 |
详情 | 详情
|
(XXVI) |
34158 |
aminoacetaldehyde dimethylacetal; 2,2-dimethoxy-1-ethanamine; 2,2-dimethoxyethylamine
|
22483-09-6 |
C4H11NO2 |
详情 | 详情
|
(XXXII) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(XXXVI) |
37412 |
methyl 2-methoxy-2-oxoacetate;dimethyl oxalate;Methyl oxalate |
553-90-2 |
C4H6O4 |
详情 | 详情
|
(XLIII) |
26655 |
methyl 4-methoxy-3-oxobutanoate;Methyl 4-methoxyacetoacetate;Methyl 4-methoxy-3-oxo-butanoate |
41051-15-4 |
C6H10O4 |
详情 | 详情
|
(XLIV) |
68600 |
methyl 3-(dimethylamino)-2-(methoxyacetyl)-2-propenoate;(Z)-methyl 2-((dimethylamino)methylene)-4-methoxy-3-oxobutanoate |
|
C9H15NO4 |
详情 | 详情
|
(XLV) |
68601 |
(Z)-methyl 2-(((2,2-dimethoxyethyl)amino)methylene)-4-methoxy-3-oxobutanoate |
|
C11H19NO6 |
详情 | 详情
|
(XLVI) |
68602 |
dimethyl 1-(2,2-dimethoxyethyl)-3-methoxy-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate |
|
C14H19NO8 |
详情 | 详情
|
(XLVII) |
68603 |
1-(2,2-dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid |
|
C13H17NO8 |
详情 | 详情
|
(XLVIII) |
68604 |
5-methoxy-6-(methoxycarbonyl)-4-oxo-1-(2-oxoethyl)-1,4-dihydropyridine-3-carboxylic acid |
|
C11H11NO7 |
详情 | 详情
|
(XLIX) |
68606 |
(4R,12aS)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid |
|
C14H16N2O6 |
详情 | 详情
|
(L) |
68605 |
(4R,12aS)-N-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide |
|
C21H21F2N3O5 |
详情 | 详情
|
合成路线14
该中间体在本合成路线中的序号:
(XXVI) Condensation of ethyl 4-chloro-3-oxobutyrate (XXX) with N,Ndimethylformamide dimethylacetal (XXXII) in EtOAc results in ethyl 2-(chloroacetyl)-3-(dimethylamino)-2-propenoate (LI), which by cyclocondensation with ethyl oxalyl chloride (XXI) by means of LiHMDS in THF affords diethyl 3-chloro-4-oxopyran-2,5-dicarboxylate (LII). Condensation of pyranone (LII) with 2,2-dimethoxyethylamine (XXVI) in EtOH gives pyridone (LIII), which is then hydrolyzed using HCOOH and H2SO4 in CH2Cl2 to yield the corresponding aldehyde (LIV). Cyclization of compound (LIV) with 3(R)-amino-1-butanol (XI) and AcOH in refluxing MeOH/toluene provides the hexahydropyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine derivative (LV), which by hydrolysis with KOSiMe3 in DME affords the hydroxy acid (LVI). Finally, acid (LVI) is coupled with 2,4-difluorobenzylamine (XIV) in the presence of HATU and NMM in DMF .
【1】
Sumino, Y., Okamoto, K., Masui, M., Yamada, D., Ikarashi, F. (Shionogi & Co., Ltd.). Process for preparing compound having HIV integrase inhibitory activity. WO 2012018065. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XI) |
68577 |
3(R)-amino-1-butanol;(R)-3-aminobutan-1-ol |
61477-39-2 |
C4H11NO |
详情 | 详情
|
(XIV) |
68578 |
2,4-difluorobenzylamine |
72235-52-0 |
C7H7F2N |
详情 | 详情
|
(XV) |
68579 |
(4R,12aS)-7-(benzyloxy)-N-(2,4-difluorobenzyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide |
|
C27H25F2N3O5 |
详情 | 详情
|
(XXI) |
11043 |
Ethyl 2-chloro-2-oxoacetate; Ethyl oxalyl chloride
|
4755-77-5 |
C4H5ClO3 |
详情 | 详情
|
(XXVI) |
34158 |
aminoacetaldehyde dimethylacetal; 2,2-dimethoxy-1-ethanamine; 2,2-dimethoxyethylamine
|
22483-09-6 |
C4H11NO2 |
详情 | 详情
|
(XXX) |
23541 |
ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloro-3-oxobutanoate;Ethyl 4-chloroacetoacetate |
638-07-3 |
C6H9ClO3 |
详情 | 详情
|
(XXXII) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(LI) |
68607 |
ethyl 2-(chloroacetyl)-3-(dimethylamino)-2-
propenoate;(E)-ethyl 4-chloro-2-((dimethylamino)methylene)-3-oxobutanoate |
|
C9H14ClNO3 |
详情 | 详情
|
(LII) |
68608 |
diethyl 3-chloro-4-oxo-4H-pyran-2,5-dicarboxylate |
|
C11H11ClO6 |
详情 | 详情
|
(LIII) |
68609 |
diethyl 3-chloro-1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate |
|
C15H20ClNO7 |
详情 | 详情
|
(LIV) |
68610 |
diethyl 3-chloro-4-oxo-1-(2-oxoethyl)-1,4-dihydropyridine-2,5-dicarboxylate |
|
C13H14ClNO6 |
详情 | 详情
|
(LV) |
68612 |
(4R,12aS)-ethyl 7-chloro-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylate |
|
C15H17ClN2O5 |
详情 | 详情
|
(LVI) |
68611 |
(4R,12aS)-7-chloro-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid |
|
C13H13ClN2O5 |
详情 | 详情
|
合成路线15
该中间体在本合成路线中的序号:
(XXVI) Condensation of ethyl 3-oxobutyrate (LVII) with N,N-dimethylformamide dimethylacetal (XXXII) in EtOAc affords ethyl 2-acetyl-3-(dimethylamino)-2-propenoate (LVIII), which by cyclocondensation with ethyl oxalyl chloride (XXI) by means of LiHMDS in THF provides diethyl 4-oxopyran-2,5-dicarboxylate (LIX). Condensation of pyranone derivative (LIX) with 2,2-dimethoxyethylamine (XXVI) in EtOH gives pyridone (LX), which is then brominated with NBS in DMF to yield the 3-bromopyridin-4-one derivative (LXI). Hydrolysis of acetal (LXI) using HCOOH and H2SO4 in CH2Cl2 yields the corresponding aldehyde (LXII), which is cyclized with 3(R)-aminobutan-1-ol (XI) in the presence of AcOH in refluxing MeOH/toluene to afford the hexahydropyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine derivative (LXIII). Finally, bromo ester (LXIII) is submitted to treatment with KOSiMe3 in DME .
【1】
Sumino, Y., Okamoto, K., Masui, M., Yamada, D., Ikarashi, F. (Shionogi & Co., Ltd.). Process for preparing compound having HIV integrase inhibitory activity. WO 2012018065. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XI) |
68577 |
3(R)-amino-1-butanol;(R)-3-aminobutan-1-ol |
61477-39-2 |
C4H11NO |
详情 | 详情
|
(XXI) |
11043 |
Ethyl 2-chloro-2-oxoacetate; Ethyl oxalyl chloride
|
4755-77-5 |
C4H5ClO3 |
详情 | 详情
|
(XXVI) |
34158 |
aminoacetaldehyde dimethylacetal; 2,2-dimethoxy-1-ethanamine; 2,2-dimethoxyethylamine
|
22483-09-6 |
C4H11NO2 |
详情 | 详情
|
(XXXII) |
11984 |
N-(Dimethoxymethyl)-N,N-dimethylamine;dimethylformamide dimethylacetal;1,1-dimethoxy-N,N-dimethylmethanamine; Dimethoxy-N,N-dimethylmethanamine; N,N-Dimethylformamide dimethyl acetal |
4637-24-5 |
C5H13NO2 |
详情 | 详情
|
(LVI) |
68611 |
(4R,12aS)-7-chloro-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid |
|
C13H13ClN2O5 |
详情 | 详情
|
(LVII) |
11819 |
ethyl acetoacetate; ethyl 3-oxobutanoate;Acetoacetic ester;Ethyl beta-ketobutyrate;ethyl 3-oxobutyrate |
141-97-9 |
C6H10O3 |
详情 | 详情
|
(LVIII) |
68613 |
ethyl 2-acetyl-3-(dimethylamino)-2-propenoate;Ethyl 2-acetyl-3-(dimethylamino)acrylate;Ethyl (2E)-2-(dimethylaminomethylidene)-3-oxobutanoate |
51145-57-4 |
C9H15NO3 |
详情 | 详情
|
(LIX) |
68614 |
diethyl 4-oxopyran-2,5-dicarboxylate;diethyl 4-oxo-4H-pyran-2,5-dicarboxylate |
|
C11H12O6 |
详情 | 详情
|
(LX) |
68615 |
diethyl 1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate |
|
C15H21NO7 |
详情 | 详情
|
(LXI) |
68616 |
diethyl 3-bromo-1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate |
|
C15H20BrNO7 |
详情 | 详情
|
(LXII) |
68617 |
diethyl 3-bromo-4-oxo-1-(2-oxoethyl)-1,4-dihydropyridine-2,5-dicarboxylate |
|
C13H14BrNO6 |
详情 | 详情
|
(LXIII) |
68618 |
(4R,12aS)-ethyl 7-bromo-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylate |
|
C15H17BrN2O5 |
详情 | 详情
|